相似文献
1
Hospital Costs of Injection Drug Use in Florida.
Clin Infect Dis. 2021 Feb 1;72(3):499-502. doi: 10.1093/cid/ciaa823.
2
A Cost Analysis of Hospitalizations for Infections Related to Injection Drug Use at a County Safety-Net Hospital in Miami, Florida.
PLoS One. 2015 Jun 15;10(6):e0129360. doi: 10.1371/journal.pone.0129360. eCollection 2015.
3
A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida.
Subst Abuse Treat Prev Policy. 2021 May 31;16(1):46. doi: 10.1186/s13011-021-00383-w.
4
Injection into the jugular vein among people who inject drugs in the United Kingdom: Prevalence, associated factors and harms.
Int J Drug Policy. 2017 Aug;46:28-33. doi: 10.1016/j.drugpo.2017.05.005. Epub 2017 Jun 3.
5
Risk Factors Associated With Skin and Soft Tissue Infections Among Hospitalized People Who Inject Drugs.
J Addict Med. 2017 Nov/Dec;11(6):461-467. doi: 10.1097/ADM.0000000000000346.
6
'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.
Harm Reduct J. 2018 May 8;15(1):23. doi: 10.1186/s12954-018-0233-y.
7
Infectious Complications in Injection Drug Use.
MedEdPORTAL. 2021 Mar 23;17:11124. doi: 10.15766/mep_2374-8265.11124.
8
Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017.
Clin Infect Dis. 2021 Oct 5;73(7):e1649-e1657. doi: 10.1093/cid/ciaa1278.
9
Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.
BMC Infect Dis. 2019 Nov 8;19(1):918. doi: 10.1186/s12879-019-4558-2.
10
Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.
Int J Drug Policy. 2020 Apr;78:102716. doi: 10.1016/j.drugpo.2020.102716. Epub 2020 Mar 5.
引用本文的文献
1
Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients', community organization and healthcare workers' perspectives.
BMC Infect Dis. 2025 Feb 14;25(1):221. doi: 10.1186/s12879-025-10617-y.
2
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.
Harm Reduct J. 2023 Dec 2;20(1):173. doi: 10.1186/s12954-023-00906-7.
3
Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs.
Open Forum Infect Dis. 2023 Jul 25;10(8):ofad402. doi: 10.1093/ofid/ofad402. eCollection 2023 Aug.
4
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.
Addict Sci Clin Pract. 2023 Feb 7;18(1):8. doi: 10.1186/s13722-023-00363-4.
5
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey.
Addict Sci Clin Pract. 2022 Nov 18;17(1):63. doi: 10.1186/s13722-022-00346-x.
6
Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
Ann Med. 2022 Dec;54(1):2137-2150. doi: 10.1080/07853890.2022.2105391.
7
Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study.
Harm Reduct J. 2021 Dec 16;18(1):131. doi: 10.1186/s12954-021-00581-6.
8
Implementation and first-year operating costs of an academic medical center-based syringe services program.
Harm Reduct J. 2021 Nov 19;18(1):116. doi: 10.1186/s12954-021-00563-8.
9
Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
Ann Med. 2021 Dec;53(1):1960-1968. doi: 10.1080/07853890.2021.1993326.
10
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.
J Subst Abuse Treat. 2021 Aug;127:108344. doi: 10.1016/j.jsat.2021.108344. Epub 2021 Mar 3.
本文引用的文献
1
HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic.
J Gen Intern Med. 2020 May;35(5):1477-1483. doi: 10.1007/s11606-020-05701-9. Epub 2020 Mar 4.
2
Human Immunodeficiency Virus and Hepatitis C Virus Infection Testing Among Commercially Insured Persons Who Inject Drugs, United States, 2010-2017.
J Infect Dis. 2020 Aug 17;222(6):940-947. doi: 10.1093/infdis/jiaa017.
3
Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers.
JAMA. 2019 Dec 10;322(22):2245-2248. doi: 10.1001/jama.2019.16196.
4
Changes in Infective Endocarditis Admissions in Pennsylvania During the Opioid Epidemic.
Clin Infect Dis. 2020 Oct 23;71(7):1664-1670. doi: 10.1093/cid/ciz1038.
5
The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
Int J Drug Policy. 2019 May;67:9-18. doi: 10.1016/j.drugpo.2018.12.015. Epub 2019 Feb 23.
6
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.
Int J Drug Policy. 2018 May;55:31-39. doi: 10.1016/j.drugpo.2018.02.001. Epub 2018 Feb 23.
7
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23.
8
Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence - North Carolina, 2010-2015.
MMWR Morb Mortal Wkly Rep. 2017 Jun 9;66(22):569-573. doi: 10.15585/mmwr.mm6622a1.
9
Discharges Against Medical Advice at a County Hospital: Provider Perceptions and Practice.
J Hosp Med. 2017 Jan;12(1):11-17. doi: 10.1002/jhm.2672.
10
Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.
Open Forum Infect Dis. 2016 Jul 26;3(3):ofw157. doi: 10.1093/ofid/ofw157. eCollection 2016 Sep.
Zotero 插件